TY - JOUR
T1 - Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial
AU - Moro, Francesca
AU - Morciano, Andrea
AU - Tropea, Anna
AU - Sagnella, Francesca
AU - Liuzzo, Giovanna
AU - Scarinci, Elisa
AU - Ciardulli, Andrea
AU - Martinez, Daniela
AU - Familiari, Alessandra
AU - Liuzzo, Giovanna
AU - Tritarelli, Alessandra
AU - Cosentino, Nicola
AU - Niccoli, Giampaolo
AU - Crea, Filippo
AU - Lanzone, Antonio
AU - Apa, Rosanna
PY - 2013
Y1 - 2013
N2 - To evaluate the long-term effects of drospirenone (DRSP)/ethinylestradiol (EE) alone, metformin alone, and DRSP/EE-metformin on CD4(+)CD28(null) T lymphocytes frequency, a cardiovascular risk marker, in patients with hyperinsulinemic polycystic ovary syndrome (PCOS).
AB - To evaluate the long-term effects of drospirenone (DRSP)/ethinylestradiol (EE) alone, metformin alone, and DRSP/EE-metformin on CD4(+)CD28(null) T lymphocytes frequency, a cardiovascular risk marker, in patients with hyperinsulinemic polycystic ovary syndrome (PCOS).
KW - CD4+CD28null T-lymphocytes
KW - drospirenone
KW - ethinylestradiol
KW - metformin
KW - polycystic ovary syndrome
KW - CD4+CD28null T-lymphocytes
KW - drospirenone
KW - ethinylestradiol
KW - metformin
KW - polycystic ovary syndrome
UR - http://hdl.handle.net/10807/53440
U2 - 10.1177/1933719113488444
DO - 10.1177/1933719113488444
M3 - Article
SN - 1933-7191
VL - 20
SP - 1508
EP - 1517
JO - Reproductive Sciences
JF - Reproductive Sciences
ER -